Middle East & Africa Hereditary Cancer Testing Market to 2032
Overview
The Middle East & Africa Hereditary Cancer Testing Market is expected to reach a 497.98 USD Million by 2032 and is projected to grow at a CAGR of 18.04% from 2025 to 2032.
Revenue, 2024 (USD Million)
209.92
Forecast, 2032 (USD Million)
497.98
CAGR, 2024 - 2032
18.04%
Report Coverage
Middle East & Africa
Middle East & Africa Hereditary Cancer Testing Market 2018-2032 USD Million
Middle East & Africa Hereditary Cancer Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 209.92 USD Million
- Projected Market Size (2032): 497.98 USD Million
- CAGR (2025-2032): 18.04%
Key Findings of Middle East & Africa Hereditary Cancer Testing Market
- The Middle East & Africa Hereditary Cancer Testing Market was valued at 209.92 USD Million in 2024.
- The Middle East & Africa Hereditary Cancer Testing Market is likely to grow at a CAGR of 18.04% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 148.64 USD Million
- The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 18.59% during the forecast period from 2024 to 2032.
Middle East & Africa Hereditary Cancer Testing Market Scope
Middle East & Africa Hereditary Cancer Testing Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Test
- Single Site Genetic Test
- Multi Panel Test
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Middle East & Africa Hereditary Cancer Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 209.92 USD Million |
| Market Value in 2032 | 497.98 USD Million |
| CAGR (2025-2032) | 18.04% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End Users,Diagnosis,Test,Disease,Technology |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 209.92 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 75.79 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 148.64 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.18 % in forecast period 2025-2032.
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By End Users
- Hospitals is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 87.57 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.59 % in forecast period 2025-2032.
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By Diagnosis
- Biopsy is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 97.66 USD Million in the year 2024.
- Biopsy is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.34 % in forecast period 2025-2032.
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By Test
- Multi Panel Test is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 140.66 USD Million in the year 2024.
- Multi Panel Test is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.40 % in forecast period 2025-2032.
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By Disease
- Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 126.86 USD Million in the year 2024.
- Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.56 % in forecast period 2025-2032.
-
Middle East & Africa Hereditary Cancer Testing Market to 2032, By Technology
- Polymerase Chain Reaction (PCR) is the largest segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a revenue of 139.04 USD Million in the year 2024.
- Polymerase Chain Reaction (PCR) is the Fastest growing segment in Middle East & Africa Hereditary Cancer Testing Market to 2032 with a Growth rate of 18.47 % in forecast period 2025-2032.
Middle East & Africa Hereditary Cancer Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| illumina, inc. | |||
| Abbott | |||
| Eurofins Scientific | |||
| LifeLabs Genetics | |||
Middle East & Africa Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Hereditary Cancer Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Diagnosis,Test,Disease,Technology.
Middle East & Africa Hereditary Cancer Testing Market was valued at USD 209.92(Revenue in USD Million) in 2020.
Middle East & Africa Hereditary Cancer Testing Market is projected to grow at a CAGR of 18.04% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Middle East & Africa Hereditary Cancer Testing Market, holding a largest market share of 148.64 USD Million in 2024
Middle East & Africa Hereditary Cancer Testing Market Scope
Middle East & Africa Hereditary Cancer Testing Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Test
- Single Site Genetic Test
- Multi Panel Test
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Frequently Asked Questions
The Middle East & Africa Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Diagnosis,Test,Disease,Technology.
Middle East & Africa Hereditary Cancer Testing Market was valued at USD 209.92(Revenue in USD Million) in 2020.
Middle East & Africa Hereditary Cancer Testing Market is projected to grow at a CAGR of 18.04% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Hereditary Cancer Testing Market for final year is USD 497.98 (USD Million).
Middle East & Africa Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Diagnosis,Test,Disease,Technology.
Middle East & Africa Hereditary Cancer Testing Market was valued at USD 209.92(Revenue in USD Million) in 2020.
Middle East & Africa Hereditary Cancer Testing Market is projected to grow at a CAGR of 18.04% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Hereditary Cancer Testing Market for final year is USD 497.98 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.